1. Home
  2. PDFS vs NEO Comparison

PDFS vs NEO Comparison

Compare PDFS & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$46.99

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.99

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
NEO
Founded
1992
2001
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2000
2008

Fundamental Metrics

Financial Performance
Metric
PDFS
NEO
Price
$46.99
$8.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$39.67
$13.38
AVG Volume (30 Days)
446.2K
2.2M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.13
$10.63
Revenue Next Year
$18.92
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.35
$4.72
52 Week High
$50.45
$13.74

Technical Indicators

Market Signals
Indicator
PDFS
NEO
Relative Strength Index (RSI) 68.16 55.37
Support Level $25.86 $7.50
Resistance Level $50.45 $10.66
Average True Range (ATR) 2.70 0.62
MACD 0.26 0.07
Stochastic Oscillator 78.40 46.59

Price Performance

Historical Comparison
PDFS
NEO

About PDFS PDF Solutions Inc.

PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: